Global Market Study on Dermatophytic Onychomycosis Therapeutics (DOT): Increasing Preference for Topical Treatment Complementing Market Growth

Jul 2021| PMR915B| Persistence Market Research

Report Highlights

Dermatophytic Onychomycosis Therapeutics (DOT) Market: Report Scope

This Persistence Market Research report examines the global dermatophytic onychomycosis therapeutics (DOT) market for the period 2021–2031. The primary objective of the report is to offer updates and information related to opportunities in the global dermatophytic onychomycosis therapeutics market.

A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index. The forecast of the DOT market by country, product type, treatment type and end users is represented in a tabular form for each region. This section will help to understand the present scenario and opportunity of the dermatophytic onychomycosis therapeutics market in major countries by each segment.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view of the key competitor firms in order to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a market segment.

The detailed profiles of players operating in the DOT market are also provided in the report, which highlight company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the report highlights the market outlook for 2021–2031 and sets the forecast within the context of the dermatophytic onychomycosis therapeutics market by region. The key regions assessed in this report include North America, Latin America, Europe, Asia Pacific, and MEA. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index.

The above sections – by product type, treatment type and end user – evaluate the historic market analysis and growth prospects of the dermatophytic onychomycosis therapeutics market for the period 2021–2031. We have considered 2020 as the base year and provided data for the forecast period.

The final section of the report represents the global scenario of the dermatophytic onychomycosis therapeutics market along with y-o-y growth and market forecast till 2031. This section also evaluates the global market opportunity over the forecast period as well as the absolute dollar opportunity for each year. This section will help to understand the overall market growth for dermatophytic onychomycosis therapeutics and the opportunity analysis for every year over the forecast period.

To arrive at the market size, bottom-up approach is used to validate the total market size obtained for dermatophytic onychomycosis therapeutics market. The forecast presented in the report provides total revenue of the dermatophytic onychomycosis therapeutics market over 2021–2031.

Persistence Market Research uses a triangulation methodology that is primarily based on experimental techniques such as patient-level data to obtain precise market estimations for dermatophytic onychomycosis therapeutics market and insights on specific country/regions. The country specific data is again analyzed to derive data at a regional level and then at a global level. This methodology ensures high quality and accuracy of information.

Several factors that were considered while developing market estimates for dermatophytic onychomycosis therapeutics market were disease epidemiology, treatment seeking rate, ratio of population prescribed with nail paints and oral drugs, dosage and prescription pattern and compliance rate.

Average Selling Price (US$) are derived by using weighted average pricing methodology.

On the other hand, Persistence Market Research also analyzed the market by considering the revenue from the key players operating in this segment. Key Players are segmented at a Tier-level with respect to their revenues, product portfolio and geographical presence.

This process involves analysis of various companies’ annual reports, Investors presentations, SEC filings, 10k reports, earning call transcripts and press releases. This task is done to fetch substantial information about the key players, their respective revenues and estimate their respective market share.

Revenue growth of key market players is analyzed over the historical period and qualitative assessment of new product launches and innovations has been made in order to validate and align the resultant market numbers.

Market structure is closely studied and analyzed at regional level to map and ascertain incremental $ opportunity for companies for instance, supply from domestic/regional players, small-scale enterprises or unorganized segments is also taken into consideration to arrive at final market numbers.

While forecasting the market size for dermatophytic onychomycosis therapeutics market, we have considered the impact of several factors such as per capital healthcare expenditure, disposable income, new product launches and approvals for dermatophytic onychomycosis therapeutics, penetration of dermatophytic onychomycosis therapeutics market products through various end users, generic penetration across all regions, etc.

However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

  • Table 1 : North America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 2 : North America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
  • Table 3 : North America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Treatment Type
  • Table 4 : North America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 5 : North America Dermatophytic Onychomycosis Therapeutics Market Participants Presence (Intensity Mapping)
  • Table 6 : Europe Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 7 : Europe Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
  • Table 8 : Europe Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Treatment Type
  • Table 9 : Europe Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 10 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Participants Presence (Intensity Mapping)
  • Table 11 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 12 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
  • Table 13 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Treatment Type
  • Table 14 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 15 : Latin America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 16 : Latin America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
  • Table 17 : Latin America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Treatment Type
  • Table 18 : Latin America Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 19 : Latin America Dermatophytic Onychomycosis Therapeutics Market Participants Presence (Intensity Mapping)
  • Table 20 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 21 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
  • Table 22 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Treatment Type
  • Table 23 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 24 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Participants Presence (Intensity Mapping)
  • Table 25 : Global Dermatophytic Onychomycosis Therapeutic products Size (US$ Mn) 2016-2020 and Forecast 2021-2031 By Region,
  • Table 26 : Global Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product Type
  • Table 27 : Global Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Treatment Type
  • Table 28 : Global Dermatophytic Onychomycosis Therapeutics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Figure 1 : North America Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2021E)
  • Figure 2 : North America Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2021E)
  • Figure 3 : North America Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2021E)
  • Figure 4 : North America Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2021E)
  • Figure 5 : North America Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 6 : North America Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 7 : U.S. Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 8 : U.S. Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 9 : Canada Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 10 : Canada Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 11 : North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2021–2031
  • Figure 12 : North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2021–2031
  • Figure 13 : North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2021–2031
  • Figure 14 : North America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2021–2031
  • Figure 15 : Europe Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2021E)
  • Figure 16 : Europe Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2021E)
  • Figure 17 : Europe Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2021E)
  • Figure 18 : Europe Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2021E)
  • Figure 19 : Europe Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 20 : Europe Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 21 : Germany Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 22 : Germany Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 23 : France Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 24 : France Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 25 : U.K. Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 26 : U.K. Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 27 : Italy Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 28 : Italy Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 29 : Spain Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 30 : Spain Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 31 : Rest of Europe Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 32 : Rest of Europe Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 33 : Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2021-2031
  • Figure 34 : Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2021-2031
  • Figure 35 : Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2021-2031
  • Figure 36 : Europe Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2021-2031
  • Figure 37 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2021E)
  • Figure 38 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2021E)
  • Figure 39 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2021E)
  • Figure 40 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2021E)
  • Figure 41 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 42 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 43 : Japan Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 44 : Japan Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 45 : China Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 46 : China Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 47 : India Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 48 : India Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 49 : ANZ Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 50 : ANZ Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 51 : Rest of APAC Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 52 : Rest of APAC Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 53 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2021-2031
  • Figure 54 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2021-2031
  • Figure 55 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2021-2031
  • Figure 56 : Asia Pacific Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2021-2031
  • Figure 57 : Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2021E)
  • Figure 58 : Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2021E)
  • Figure 59 : Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2021E)
  • Figure 60 : Latin America Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2021E)
  • Figure 61 : Latin America Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 62 : Latin America Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 63 : Brazil Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 64 : Brazil Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 65 : Mexico Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 66 : Mexico Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 67 : Argentina Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 68 : Argentina Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 69 : Rest of LAM Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 70 : Rest of LAM Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 71 : Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2021-2031
  • Figure 72 : Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2021-2031
  • Figure 73 : Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2021-2031
  • Figure 74 : Latin America Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2021-2031
  • Figure 75 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Share By Country (2021E)
  • Figure 76 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Share By Product Type (2021E)
  • Figure 77 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Share By Treatment Type (2021E)
  • Figure 78 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Share By Distribution Channel (2021E)
  • Figure 79 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 80 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 81 : GCC Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 82 : GCC Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 83 : South Africa Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 84 : South Africa Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 85 : Rest of MEA Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 86 : Rest of MEA Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 87 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Country, 2021-2031
  • Figure 88 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2021-2031
  • Figure 89 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2021-2031
  • Figure 90 : Middle-East & Africa Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2021-2031
  • Figure 91 : Global Lithotripsy Devices Share Analysis (%), By Region, 2021 & 2031
  • Figure 92 : Global Lithotripsy Devices Y-o-Y Analysis (%), By Region, 2021-2031
  • Figure 93 : Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Region, 2021-2031
  • Figure 94 : Global Lithotripsy Device Market Share Analysis (%), By Product Type, 2021 & 2031
  • Figure 95 : Global Lithotripsy Device Market Y-o-Y Analysis (%), By Product Type, 2021-2031
  • Figure 96 : Tablets Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 97 : Tablets Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 98 : Nail Paints Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 99 : Nail Paints Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 100 : Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Product Type, 2021-2031
  • Figure 101 : Oral Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 102 : Oral Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 103 : Topical Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 104 : Topical Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 105 : Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Treatment Type, 2021-2031
  • Figure 106 : Global Dermatophytic Onychomycosis Therapeutics Market Share Analysis (%), By Distribution Channel, 2021 & 2031
  • Figure 107 : Global Dermatophytic Onychomycosis Therapeutics Market Y-o-Y Analysis (%), By Distribution Channel, 2021-2031
  • Figure 108 : Global Dermatophytic Onychomycosis Therapeutics Market Attractiveness Analysis By Distribution Channel, 2021-2031
  • Figure 109 : Global Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2016-2020
  • Figure 110 : Global Dermatophytic Onychomycosis Therapeutics Market Value Analysis (US$ Mn), 2021-2031
  • Figure 111 : Global Dermatophytic Onychomycosis Therapeutics Market Absolute $ Opportunity, 2021-2031

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report